Cargando…

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue

BACKGROUND: Extremely dense breast tissue is associated with increased breast cancer risk and limited sensitivity of mammography. The DENSE trial showed that additional magnetic resonance imaging (MRI) screening in women with extremely dense breasts resulted in a substantial reduction in interval ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geuzinge, H Amarens, Bakker, Marije F, Heijnsdijk, Eveline A M, van Ravesteyn, Nicolien T, Veldhuis, Wouter B, Pijnappel, Ruud M, de Lange, Stéphanie V, Emaus, Marleen J, Mann, Ritse M, Monninkhof, Evelyn M, de Koekkoek-Doll, Petra K, van Gils, Carla H, de Koning, Harry J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562952/ https://www.ncbi.nlm.nih.gov/pubmed/34585249 http://dx.doi.org/10.1093/jnci/djab119

Ejemplares similares

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
por: Zielonke, Nadine, et al.
Publicado: (2021)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Validation of Combined Deep Learning Triaging and Computer-Aided Diagnosis in 2901 Breast MRI Examinations From the Second Screening Round of the Dense Tissue and Early Breast Neoplasm Screening Trial
por: Verburg, Erik, et al.
Publicado: (2023)

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
por: de Gelder, Rianne, et al.
Publicado: (2011)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
por: Zielonke, Nadine, et al.
Publicado: (2023)

Geographic variation in volumetric breast density between screening regions in the Netherlands
por: van der Waal, Daniëlle, et al.
Publicado: (2015)

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening
por: Sankatsing, Valérie D. V., et al.
Publicado: (2018)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Volumetric breast density affects performance of digital screening mammography
por: Wanders, Johanna O. P., et al.
Publicado: (2016)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Correction: Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts
por: van Zelst, Jan C. M., et al.
Publicado: (2018)

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs
por: van der Poort, Esmée K. J., et al.
Publicado: (2022)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
por: Getaneh, Abraham M., et al.
Publicado: (2021)

The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort
por: Wanders, Johanna Olga Pauline, et al.
Publicado: (2015)

The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study
por: Wanders, Johanna O. P., et al.
Publicado: (2017)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkers
por: Menezes, Gisela L. G., et al.
Publicado: (2019)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study
por: Bozhar, H., et al.
Publicado: (2022)

Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female population
por: Clarijs, Marloes E., et al.
Publicado: (2022)

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
por: Mann, Ritse M., et al.
Publicado: (2022)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

Modeling the natural history of ductal carcinoma in situ based on population data
por: Chootipongchaivat, Sarocha, et al.
Publicado: (2020)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

Quantification of masking risk in screening mammography with volumetric breast density maps
por: Holland, Katharina, et al.
Publicado: (2017)

A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography
por: Michalopoulou, Eleni, et al.
Publicado: (2023)

Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths
por: de Gelder, R, et al.
Publicado: (2011)

Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation
por: Arrospide, Arantzazu, et al.
Publicado: (2015)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, L., et al.
Publicado: (2020)

Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis
por: Arrospide, Arantzazu, et al.
Publicado: (2016)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jaq9titdvgp2fhh6301mjni03e